The largest database of trusted experimental protocols

8 protocols using tezacaftor

1

Synthesis and Evaluation of CFTR Modulators

Check if the same lab product or an alternative is used in the 5 most similar protocols
The molecules, 2a, 7a, and 7m, were synthetised, as previously published [37 (link),38 (link)]. The known CFTR modulators, Tezacaftor, VX661, Elexacaftor, VX445 and Ivacaftor, and VX770 were purchased from Selleck Chemicals (Munich, Germany). If not explicitly indicated in the text, all other chemicals and culture media components were provided by Merck (Milan, Italy).
+ Open protocol
+ Expand
2

CFTR Functional Assay in Bronchial Epithelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CF HNECs were differentiated from ALI + 0 to 21 days in the presence or absence of 125 nM LY450139 with and without 3 µM elexacaftor and 3 µM tezacaftor (Selleckchem). Transwells were mounted in an Ussing chamber for electrophysiological short circuit current (Isc) measurements using standard methods (34 (link)). Solutions in the serosal and mucosal baths were prepared so that a chloride gradient was established between both sides. After stable baseline current recordings were obtained, agonists were added in the following order to the apical side: amiloride (10 µM) to block sodium channel activity, IBMX and forskolin (10 µM) to stimulate CFTR through increased cAMP, ivacaftor (10 µM) to potentiate CFTR activity, and CFTRinh-172 (20 µM) to block CFTR current. For each agonist, signals were monitored until a plateau in current was noted before adding the next agonist. The delta-Isc in response to CFTRinh-172 was used as the chief readout for CFTR-mediated chloride transport.
+ Open protocol
+ Expand
3

CFTR Mutant Rescue Assay in FRT Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fisher Rat Thyroid (FRT) cells stably transfected with a wild type (WT) CFTR, or CFTR carrying the cystic fibrosis mutation p.F508del, were grown at 37 °C and 5% CO2 in modified F12 Coon’s medium with addition of 10% FBS and, 2 mM of Glutamine, 1 mg ml−1 penicillin, 100 µg ml−1 streptomycin and the addition of 1 mg ml−1 geneticin (G418) and 0.6 mg ml−1 zeocin as selection agents. For the iodide influx assay, cells stably co-transfected with the halide-sensitive yellow fluorescent protein, YFP-p.H148Q/p.I152L28 (link),29 (link), were seeded in 96-well microplates at a density of 40,000 cells/well. For intracellular pH measurements, cells were seeded on glass-bottom Petri dishes. Measurements were carried out 48 h after seeding. To evaluate the correctors p.F508del rescue on the cells expressing the mutated CFTR, cells were incubated for 18 h with 5 µM of VX809 (lumacaftor; Selleck Chemicals, Huston, TX, USA), VX661 (tezacaftor; Selleck Chemicals), Corr4a (ChemBridge Corp. San Diego, CA, USA), or 2.5 µM of VX809 with 2.5 µM of Corr4a together (final concentration 5 µM). Except when indicated, all chemicals compounds were purchased from Sigma-Aldrich (Milan, Italy).
+ Open protocol
+ Expand
4

Screening of CFTR Modulator Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following chemicals were used: DMSO (Sigma-Aldrich, St Louis, MO, Cat# D2650), MG-132 (Cayman Chemical, Ann Arbor, MI, Cat# 10012628), Lumacaftor (Cayman Chemical, Cat# 22196), Tezacaftor (Selleck Chemicals, Houston, TX, Cat# S7059), Elexacaftor (Selleck Chemicals, Cat# S8851), Ivacaftor (Chemscene LLC, Monmouth Junction, NJ, Cat# CS-0497), cycloheximide (CHX, FUJIFILM Wako Pure Chemical Corporation, Osaka, Japan, Cat# 3720991), doxycycline (dox, FU-JIFILM Wako Pure Chemical Corporation, Cat# 049-31121), glycerol (FU-JIFILM Wako Pure Chemical Corporation, Cat# 075-00616), cyclosporin A (CLP-A, FU-JIFILM Wako Pure Chemical Corporation, Cat# 031-24931), E-4031 (Selleck Chemicals, Cat# S6627). Hit compounds from the in silico screening and the FR3 analog compounds are listed in Supplementary Table S1.
+ Open protocol
+ Expand
5

Pharmacological Inhibition of TRPC6 and CFTR

Check if the same lab product or an alternative is used in the 5 most similar protocols
Roscovitine and M3 were synthesized at ManRos Therapeutics and used at concentrations ranging from 0.1 to 100 μM. TRPC6 inhibitor17 (link) was provided by Dr. Stephanie Häfner and used at 10 µM. CFTR modulators tezacaftor and ivacaftor (Selleck chem) were used at 5 µM. Cysteamine (Sigma) was used at 5 µg/ml and the CFTR inhibitor Inh-172 (Sigma) was used at 5–10 µM. All reagents were dissolved in DMSO and therefore non-treatment conditions received equal DMSO concentrations. All reagents were given as pre-treatment for 6 h prior to general infection experiments, and 4 h prior to halide efflux and phagocytosis.
+ Open protocol
+ Expand
6

CFTR Modulators Evaluation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
All chemicals were of analytical grade. DMSO, Forskolin and Genistein were obtained from Sigma Aldrich, ivacaftor, tezacaftor and elexacaftor from Selleckchem (United States), and CFTR-inh172 from MedChemexpress (United States). All compounds were dissolved in DMSO.
+ Open protocol
+ Expand
7

Bronchial Epithelial Cell Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
CF primary human bronchial epithelial cells were cultured at the ALI and treated with tezacaftor (VX-661), elexacaftor (VX-445), and ivacaftor (VX-770) (Selleck Chemicals) for 72 hours at 3 μM, 1 μM, and 3 μM, respectively. The media with ETI were refreshed every 24 hours.
+ Open protocol
+ Expand
8

Evaluation of CFTR Modulators in Vitro

Check if the same lab product or an alternative is used in the 5 most similar protocols
ELX-02 test article was diluted in Type 1 Milli-Q water to a stock concentration of 20 mg/mL. CFTR inhibitor 172 and CFTR inhibitor-II were sourced from Sanbio and stock solutions were prepared in dimethyl sulfoxide (DMSO). Ivacaftor (VX-770) was supplied by Bio Connect, lumacaftor (VX-809) and tezacaftor (VX-661) were each supplied by Selleck Chem and stock solutions prepared in DMSO. Clinically, Orkambi R is prepared in a dosage form of 200 mg lumacaftor and 125 mg ivacaftor and Symdeko R is prepared in a dosage form of 100/150 mg tezacaftor and 150 mg ivacaftor.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!